Previous 10 | Next 10 |
Staffing 360 Solutions, Inc. (STAF) -19% after pricing $7.58M registered direct offering.NeuroBo Pharmaceuticals, Inc. (NRBO) -13%.Nova LifeStyle, Inc. (NVFY) 2%.Aehr Test Systems (AEHR) -7%.Ardelyx, Inc. (ARDX) -6%.TD Holdings, Inc. (GLG) -5%. For further details see: Ardelyx...
Best Biotech Penny Stocks to Watch in July 2021 Biotech penny stocks remain some of the hottest stocks of the year so far. While there are hundreds of penny stocks in the biotech industry to choose from, only a handful have a lot to offer investors of all types. To understand which,...
Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...
Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Life Clips (OTCMKTS: LCLP ) stock is falling on Tuesday following an update from the battery company. Source: John Brueske/Shutterstock.com But before that let’s talk about how the stock’s moving...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Neurobo Pharmaceuticals (NASDAQ: NRBO ) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company. Source: Bukhta Yurii / Shutterstock.com The recent interest from retail trader...
Gainers: NeuroBo Pharmaceuticals (NRBO) +50%, NeuroMetrix (NURO) +41%, Immunome (IMNM) +31%, Endo International (ENDP) +21%, PLx Pharma (PLXP) +18%.Losers: Ardelyx (ARDX) -75%, Allied Healthcare Products (AHPI) -22%, NRx Pharmaceuticals (...
NeuroBo Pharmaceuticals (NRBO) +36%.Immunome (IMNM) +29% rallies 31% after antibody cocktail neutralizes Delta variant in pre-clinical testingMediWound (MDWD) +19% announces positive topline results from Phase 3 pediatric ctudy (CIDS) of nexoBrid for eschar removal of seve...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We’re getting ready for another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday! Source: oneinchpunch/Shutterstock.com But before that, check out what the ...
Gainers: Clearside Biomedical (CLSD) +30%, Eloxx Pharmaceuticals (ELOX) +15%, Fusion Pharmaceuticals (FUSN) +14%, Precipio (PRPO) +14%, Ocugen (OCGN) +11%.Losers: PDS Biotechnology (PDSB) -27%, Sage Therapeutics (SAGE) -16%, Neu...
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01 PR Newswire CAMBRIDGE, Mass. , July 30, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transfo...
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...